Lessons on Design Thinking from P&G and Pfizer
Learn more on the how, and why, both P&G and Pfizer view design thinking as a tool set that helps individuals and companies problem-solve.
Opening the Door to Patients
The Open House concept was born towards the end of 2014 when Janssen was approached by a large patient group in the oncology space. The group asked if the company would be interested in supporting them in work that they felt would contribute towards improving patient outcomes. As discussions progressed, it became clear that a new model of interaction might be appropriate.
It takes two to tango: how shared decision making can help patients and providers make better decisions together
Shared Decision Making
Thursday, September 15, 2016 at 1 PM in Paul Brest Hall, Stanford University.
You make decisions every day. Some are good; some are not as good. Did you know there is a science to decision making that can help people make better decisions more often? In collaboration with Eli Lilly, Medicine X will facilitate a half-day design workshop about improving decision making for patients and providers.
Do Patents Promote or Hinder Innovation
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
The Communities of Practice concept is a key lever for innovation, but often overlooked. The best innovation programs leverage CoPs to support continuous innovation across an organization.
WEBINAR: How Pfizer Built a Global Innovator Network
Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions” over scarcely more than two years.
Using the Internet to Raise Disease Awareness
The continued rise of social media and the various fundraiser pages can be great for any disease awareness campaign. Patients who have the diseases that are being campaigned for are more likely to engage via social media than the other campaign methods.
Strategies for Patient Engagement
Positive and credible engagement of patients is critical for completion of clinical trials and to achieve business results. The CLEAR method leverages: credibility, literacy, expectation management, accessibility and that relates to patients. Read More...
Precision Medicine Intiative
Precision Medicine is an innovative approach that takes into account individual differences in people’s genes, environments, and lifestyles. Read More...
Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey
This study aims to gain a better understanding of attitudes and practices for engaging patient groups.
Partnership between Pharma and Patients
Jane Griffiths, Company Group Chairman, Janssen EMEA discusses the relationship between industry and patients. Read More...
Learning more from Patients Regarding Engagement
What can learn pharma from patients regarding engagement expectations including data collection, communication and the usage of technology. Read More...
A Focus on People, Ideas and Culture: Bayers Model of Innovation
Bayer's model of innovation is a holistic model for people and their ideas. The model assists with the creation, nurturing, and enhancing of people and ideas.
Engaging patients for drug repurposing: Mapping the patient engagement continuum
The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.
Patient Research Priorities
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers.
Patient Engagment/Engaged Thinking Social Community Launched
September 18 2015
Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".
Listening to Patients
In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.
Continuing Reading More Innovation News and Blogs...